By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
IndebtaIndebta
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Notification Show More
Aa
IndebtaIndebta
Aa
  • Banking
  • Credit Cards
  • Loans
  • Dept Management
  • Mortgage
  • Markets
  • Investing
  • Small Business
  • Videos
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Follow US
Indebta > Investing > Royal Philips’s 2023 Sales Growth, Margin Seen Within Guidance — Earnings Preview
Investing

Royal Philips’s 2023 Sales Growth, Margin Seen Within Guidance — Earnings Preview

News Room
Last updated: 2024/01/27 at 10:52 AM
By News Room
Share
3 Min Read
SHARE

By Elena Vardon

Royal Philips is scheduled to report results for its fourth quarter and 2023 on Monday. Here is what you need to know:


SALES FORECAST: The Dutch health-technology company is expected to post 5.33 billion euros ($5.79 billion) in sales for the three months ended Dec. 31, according to a company-compiled consensus, against EUR5.42 billion in the same quarter the previous year. Estimates have comparable sales growth at 2.6% for the period. Deutsche Bank analysts expect a decent quarter “driven by continued solid growth in the diagnostics & treatment and personal-health segments, whereas the connected-care segment should be weak,” they wrote in a note. Consensus pencils EUR18.44 billion in sales for 2023. Comparable sales growth for the full year is seen at 6.8%, while the company recently lifted its guidance to between 6% and 7% growth for the year.


ADJUSTED EBITA MARGIN FORECAST: Philips’s adjusted earnings before interest, taxes and amortization margin is expected at 12.6% by consensus for the quarter and 10.5% for the year, against its 2023 guidance of a 10% to 11% margin.


NET INCOME FORECAST: Analysts estimate that the Amsterdam-listed group will report EUR331 million in net income attributable to shareholders for the quarter–compared with EUR157 million in the fourth quarter of 2022–and a narrower net loss for 2023 at EUR174 million.


WHAT TO WATCH:

–2024 OUTLOOK: The company is expected to guide for mid-single-digit organic sales growth and 50 to 100 basis points of adjusted earnings EBIT margin expansion, in line with consensus expectations, according to Deutsche Bank analysts.

–ORDER INTAKE: Investors will be watching Philips’s quarterly new orders closely after its third-quarter intake fell given high comparisons, lower orders in China and longer lead times.

–RESPIRONICS RECALL: Analysts don’t expect a meaningful update on the recall of its sleep apnea devices at these results. The overhang from the recall is expected to offset the company’s recovery, ING analyst Marc Hesselink wrote in a note.

Philips shares have gained 42% in the past 12 months and trade at EUR21.05.


Write to Elena Vardon at [email protected]


Read the full article here

News Room January 27, 2024 January 27, 2024
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Finance Weekly Newsletter

Join now for the latest news, tips, and analysis about personal finance, credit cards, dept management, and many more from our experts.
Join Now
Why retirees are finally taking crypto seriously

Watch full video on YouTube

Where Did All The Good Jobs Go?

Watch full video on YouTube

Kodiak Sciences Inc. (KOD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Anupam RamaJPMorgan Chase & Co, Research Division All right. Welcome, everyone, to…

President Trump announces Dell founder will donate $6.25 billion to fund Trump accounts for kids

Watch full video on YouTube

Why the U.S. retirement system has a C+ rating

Watch full video on YouTube

- Advertisement -
Ad imageAd image

You Might Also Like

Investing

Nursing Home Stocks Could Suffer from this Medicaid Spending Remedy

By News Room
Investing

Bitcoin Drops Below $90,000 Again. What Could Move It Next.

By News Room
Investing

These Stocks Are Moving the Most Today: Marvell, Nvidia, Broadcom, GM, Tesla, MongoDB, Burlington, and More

By News Room
Investing

Nvidia Stock Falls as Marvell Earnings Compound AI Gloom. The Rising Risks for Chips.

By News Room
Investing

This analyst says Tesla deliveries will be 16% below expectations. Musk is part of the problem.

By News Room
Investing

BP CEO was awarded no bonus pay from oil giant’s financial performance

By News Room
Investing

Shares of Starlink’s European competitor have tripled. CEO says it can do the job in Ukraine.

By News Room
Investing

GE Vernova Stock Rises as Analyst Flips to Upgrade After Rating Cut

By News Room
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Press Release
  • Contact
  • Advertisement
More Info
  • Newsletter
  • Market Data
  • Credit Cards
  • Videos

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions
Join Community

2023 © Indepta.com. All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?